Ruiting Liang

Ruiting Liang is a seasoned professional in analytical development with extensive experience in the biopharmaceutical industry. Currently serving as the Director of Analytical R&D at BeiGene since August 2021, Ruiting is responsible for early-stage analytical development of small molecule drugs. Prior roles include Senior Scientist in Process Development at Amgen, leading a team focused on attribute sciences, and managing analytical development processes at Alkermes. Ruiting has also contributed to antisense oligonucleotide programs at Biogen and provided analytical support in a GMP environment at Nitto Avecia. Ruiting's career began with an internship in technology licensing at the University of Rochester Medical Center and an analytical development internship at Bayer HealthCare. Ruiting holds a Doctorate in Chemistry from the University of Rochester, alongside degrees in Chemistry and Computer Software Engineering from Peking University.